Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2020 Earnings Conference Call May 6, 2020 8:30 AM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President and Chief Executive Officer Rafael Amado - Executive Vice President, Research and Development and Chief Medical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Biren Amin - Jefferies Matthew Holt - JPMorgan Marc Frahm - Cowen & Company Mark Breidenbach - Oppe ...